Evidence map›Paper›PMID 34749207›Full record

ReviewPathology, research and practice2021

Host factors: Implications in immunopathogenesis of COVID-19.

Roghayeh Jafarpour, Salar Pashangzadeh, Razieh Dowran

Open access · greenAbstract readReview
In one paragraph

Review in Pathology, research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Genetic variants inFrontiers in genetics · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Roghayeh JafarpourDepartment of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Salar PashangzadehIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran; Immunology Today, Universal Scientific Education and Research Network (USERN), Tehan, Iran.
Razieh DowranDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: dowranr@razi.tums.ac.ir.
Iran University of Medical Sciences · IRIranian Institute for Health Sciences Research · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is more serious in people with underlying diseases, but the cause of healthy people with progressive disease is largely unknown. Host genetic factors such as ACE2 variants, IFITM-3, HLA, TMRSS2, and furin polymorphisms appear to be one of the agents involved in the progression of the COVID-19 and outcome of the disease. This review discusses the general characteristics of SARS-CoV-2, including viral features, receptors, cell entry, clinical findings, and the main human genetic factors that may contribute to the pathogenesis of COVID-19 and get the patients' situation more complex. Further knowledge in this context may help to find a way to prevent and treat this viral pneumonia.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19FurinGenetic Predisposition to DiseaseHLA AntigensHumansMembrane ProteinsPolymorphism, GeneticRNA-Binding ProteinsSARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2FurinFURIN protein, humanHLA AntigensIFITM3 protein, humanMembrane ProteinsRNA-Binding ProteinsACE2COVID-19Genetic susceptibilityPolymorphismsSARS-CoV-2

Identifiers

PMID34749207
PMCPMC8505027
OpenAlexW3205401125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.